{
  "id": "f8f15d1a20eac590",
  "title": "Acute Myeloid Leukemia Clinical Trial Pipeline Appears Robust With 100+ Key Pharma Companies Actively Working in the Domain | DelveInsight",
  "description": "Acute myeloid leukemia (AML) is an aggressive cancer of the blood and bone marrow, characterized by rapid growth of abnormal white blood cells. As AML primarily affects older adults, the global rise in aging populations is significantly increasing the at-risk\u2026",
  "content": "New York, USA, Dec. 04, 2025 (GLOBE NEWSWIRE) -- Acute Myeloid Leukemia Clinical Trial Pipeline Appears Robust With 100+ Key Pharma Companies Actively Working in the Domain | DelveInsight\r\nAcute myel\u2026 [+16656 chars]",
  "source": "GlobeNewswire",
  "source_url": "https://www.globenewswire.com/news-release/2025/12/04/3200202/0/en/Acute-Myeloid-Leukemia-Clinical-Trial-Pipeline-Appears-Robust-With-100-Key-Pharma-Companies-Actively-Working-in-the-Domain-DelveInsight.html",
  "published_at": "2025-12-04T18:00:00Z",
  "fetched_at": "2025-12-06T18:33:06.472112+00:00",
  "category": "ai_machine_intelligence",
  "subcategory": null,
  "keywords": [
    "ai",
    "aging",
    "search:regulatory agency action"
  ],
  "location": null,
  "raw_data": {
    "source": {
      "id": null,
      "name": "GlobeNewswire"
    },
    "author": "DelveInsight Business Research LLP",
    "title": "Acute Myeloid Leukemia Clinical Trial Pipeline Appears Robust With 100+ Key Pharma Companies Actively Working in the Domain | DelveInsight",
    "description": "Acute myeloid leukemia (AML) is an aggressive cancer of the blood and bone marrow, characterized by rapid growth of abnormal white blood cells. As AML primarily affects older adults, the global rise in aging populations is significantly increasing the at-risk\u2026",
    "url": "https://www.globenewswire.com/news-release/2025/12/04/3200202/0/en/Acute-Myeloid-Leukemia-Clinical-Trial-Pipeline-Appears-Robust-With-100-Key-Pharma-Companies-Actively-Working-in-the-Domain-DelveInsight.html",
    "urlToImage": "https://ml.globenewswire.com/Resource/Download/dbcddd65-71dd-4559-8875-ae89ac4f96db",
    "publishedAt": "2025-12-04T18:00:00Z",
    "content": "New York, USA, Dec. 04, 2025 (GLOBE NEWSWIRE) -- Acute Myeloid Leukemia Clinical Trial Pipeline Appears Robust With 100+ Key Pharma Companies Actively Working in the Domain | DelveInsight\r\nAcute myel\u2026 [+16656 chars]"
  }
}